Forever Youth Technology is a biochemical company that is two years old. Its main product, an antioxidant drink that is supposed to energize the consumer and delay aging, is still under development. The company’s equity consists of $5 million invested by its founders and $5 million from a venture capitalist. The company has spent $3 million in each of the past two years, mostly on lab equipment and R&D costs. The company has had no sales so far. What are the challenges associated with valuing such a young and uncertain company?